title: Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication.
authors.forename: A A
authors.initials: AA
authors.lastname: Claessens
authors.forename: E R
authors.initials: ER
authors.lastname: Heerdink
authors.forename: J T
authors.initials: JT
authors.lastname: van Eijk
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
authors.forename: H G
authors.initials: HG
authors.lastname: Leufkens
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D064747:Lansoprazole; D009853:Omeprazole